CTRC Lab 1. R (old EC area) Rose Zone Elevator A. 16 beds and 2 chair rooms. Vivian Dorsey RN,BSN, MBA,OCN Nurse Manager

Size: px
Start display at page:

Download "CTRC Lab 1. R (old EC area) Rose Zone Elevator A. 16 beds and 2 chair rooms. Vivian Dorsey RN,BSN, MBA,OCN Nurse Manager"

Transcription

1 Clinical & Translational Research Center CTRC Overview Vivian Dorsey RN,BSN, MBA,OCN Nurse Manager 1 7/30/2009 New Location R (old EC area) Rose Zone Elevator A 16 beds and 2 chair rooms 2 7/30/2009 CTRC-Purpose Outpatient treatment center dedicated to implementing complex Phase I/II studies Dedicated unit for innovative drug development programs Manage the administration of novel investigational agents and coordination of care, lab, Ekgs 3 7/30/2009 CTRC Lab 1

2 Value of the CTRC Provides the infrastructure for clinical research in a controlled environment Administration of investigational agents by experienced RN staff Phlebotomy services-collection, processing, shipping and tracking, storage and quality monitoring Med Tech Available M-F 7-9 pm, EKG services 4 7/30/2009 CTRC Leadership Team Daniel Karp MD, Med Director Cynthia Stewart, RN, MSN, CAD Vivian Dorsey RN, BSN, MBA,OCN,NM Portia Tse, RN, MS,OCN,ANM Dina Harleaux-Grant, RN, BSN, MCPA Passion Sparrow, PhD Lab Mgr, CTRC Kirk Culotta, Pharm D 5 7/30/2009 CTRC: Utilization Process Budget development for CTRC patient care charges and PK costs with CRF submission Submit Utilization Request via Lotus to CTRC box Review of requested resources by CTRC Review Committee Participate in site initiation meeting Arrange in-service for staff-orders, kits, lab sheet 6 7/30/2009 CTRC Lab 2

3 CTRC Hours of Operation Nursing: M and F 7am-11pm T,W, Th 7am-2:30am Lab: M-F 24 hr availability, after 11pm simple time points only Sat/Sun 7am-3:30pm: simple treatments only, no course 1 day 1 complex treatments Closed all institutional holidays 7 7/30/2009 CTRC Contact Numbers Nursing: Tel: Fax: PK Lab: Tel: Fax: Patients must be scheduled to both areas. Notify us of changes, delays, and cancellations Communication is the key! 8 7/30/2009 Scheduling Fax requests to nursing and lab at the same time to schedule pts Limited number of long studies we can accommodate on a daily basis-limited space, staff, want to ensure safe delivery of protocol Course 1, day 1 treatments must be started by 2 pm, M-F patient safety issue-staffed to manage ADR, research staff available to respond to emergencies 9 7/30/2009 CTRC Lab 3

4 Scheduling Lab scheduler is available M-F 7-3:30. Requests submitted after 3:30, will be managed the next business day. Please follow up to ensure your patient was scheduled correctly. We have over 1500 visits per month and receive over 100 faxes a day. 10 7/30/2009 Scheduling Submit cancellation request to lab and nursing, if pt is off study or admitted Call for same day scheduling-must be approved by nursing and lab managers (need to assure adequate staffing, kits, resources) Kits are kept off site in CPB 11 7/30/2009 FYI Patients must arrive chemo ready- we need to have complete orders, IV, labs assessment PAC-New or never accessed at MDACC, they have to be evaluated by infusion therapy and have an X-Ray on file before we can use the port infusion therapy 12 7/30/2009 CTRC Lab 4

5 FYI Send patients to Infusion Therapy for IV placement prior to coming to CTRC If your patient will be treated after 5pm M-F and on the W/E, provide correct contact information for issues or patient concerns. 13 7/30/2009 FYI Home clinics are responsible for scheduling all labs If there are any specific requirements for the protocol, it must be written on the orders 14 7/30/2009 FYI After 1 st patient treated, you need to review our data and contact us if there are any deviations (real time review, not months later) All patients have to be scheduled, we do not accept drop ins A schedule is essential to our managing our increasing volume Notify us if the patient is delayed past their appointment time 15 7/30/2009 CTRC Lab 5

6

7 Z-Code Marsha Hofweber Office of Research Education and Regulatory Management Z-Code Objectives Define Z-Code Be able to state situation for appropriate use of Z-Code State process for requesting Z-Code Describe collection process for Z-Code specimen What Is A Z-Code? A system for the purpose of requesting the Diagnostic Centers and the Inpatient Units to collect protocol specific blood specimens. 1

8 In Which Situations May Z-Codes Be Used? Only MDA standard collection tubes Timed specimens do not qualify (pharmacokinetics) Allows coordination of drawing research and routine labs simultaneously How Is A Z-Code Requested? Make request a minimum of 3 weeks prior to protocol initiation Form located in Bulletin of Information Protocol number required Cost Center number required Dedicated pager for life of protocol required 2

9 Check Research Protocol 3

10 Blood Collection for Research Purposes Make Note A different Z-Code will be necessary if blood tests are not identical for each visit. What is the Process for Collecting Z- Coded Blood? Research labs are ordered on form called Outpatient Physician Orders Research Protocol Diagnostic Tests 4

11 Research Protocol Diagnostic Tests Clinic Station and select patient Click on Orders Select Research Protocol Research Protocol Diagnostic Tests (will always be at the top of the list of orders) Form will be populated with patient information What is the Process for Collecting Z- Coded Blood? Lab will print protocol specific instructions with patient specific tube labels Processing area staff pages protocol pager for collection Specimens held up to 48 hours 5

12 Summing Up.. No special tubes may be used Pick up blood specimens within 48 hours Proactive- Check processing area if protocol patient scheduled for blood draw even if page for blood pick up not received Pager number unchanged for life of protocol Plan ahead 6

13

14 CLINICAL RESEARCH TRAINING INVESTIGATIONAL PHARMACY SERVICES Investigational Pharmacy Services Sapna Amin, PharmD, BCOP, Kimberly McConnell, PharmD What is an Investigational Drug? Investigational Drug: Any drug that has not yet been approved for commercial use and has not been cleared for sale in interstate commerce by the FDA. This can include any drug that has not yet been approved for the labeled indication by the FDA. (Safety Standards for Medication Use Section 2:10.01) If the study is being conducted under an IND, by definition it is considered an investigational agent regardless of commercial availability Investigational Pharmacy Service >200 Investigational Agents >900 Active Protocols at MDACC Many Protocols also include investigational use of commercially available agents Different dosing, regimens or indications 1

15 Investigational Pharmacy Service Leadership Team Manager: Sapna Amin, PharmD, BCOP Charge Pharmacist: Kim McConnell, PharmD Staff Pharmacists: Madhu Bharatula, MS, RPh Abel Montalvo, MS, RPh Jason Reed, RPh Location and office hours for IPS Location: Main Building, Room B Telephone: (713) Facsimile: (713) Office Hours: Mon-Fri: 8am 5:00pm Saturday: 8am 4:30pm Sunday: 12noon 4:00pm After hours coverage is provided by Technicians and On-Call Service Pharmacists Clinical Services Participation in Protocol Review and Discussion at IRB and CRC Provide support and drug information for all Drug Treatment Protocols Conducted at MD Anderson Cancer Center Review and Assistance in the Development of Physician Order Sets 2

16 Operational Services Pharmaceutical Management of all Investigational Protocols that include drug therapy at MD Anderson Cancer Center Protocol Initiation Procurement and Storage Accountability of Doses Dispensed Resolution of Discrepancies Monitor Visits and Audits Protocol Close Out Randomization and Blinding of Doses Inventory Procurement & Maintenance Ship To Address: MD Anderson Cancer Center Investigational Pharmacy Services 1515 Holcombe Blvd, B Houston, Texas Protocol Activation Office of Protocol Research (OPR) must verify drug arrival for protocol activation. A request for Protocol Activation must be submitted by the Study Team to OPR OPR will contact Investigational Pharmacy to verify that inventory has been received Some exceptions do exist (Example: NCI Protocols that require Patient enrollment prior to Inventory Shipment) 3

17 Dispensing Study Drug A Prescription or Order is required for Study Drug to be dispensed The Patient MUST be entered into PDMS/CORe for dispensing i to occur An accession number will be assigned to the Patient via CORe; Please include this number on the Prescription or Order Pharmacy Staff will verify this information prior to dispensing Investigational Pharmacy Record Keeping Source Documentation Includes: Dose Dispensing and Inventory Movement Sponsor Contact Information Shipment Receipt Sponsor Correspondence Pharmacy Preparation Information Sponsor Visit Tracking All Other Information Pertinent to Pharmacy 4

18 Requesting Data Data coordinators can request dispensing record by filling out Investigational Drug services data request form which can be obtained on line at The requests should include Protocol Number Patient Information Range of dates needed Requestor s Contact Information Reason for Request Monitoring/Auditing visits In order to reserve adequate time for each visit Two to Four weeks advance notification is required for an appointment We will do our best to accommodate all requests Schedule via telephone (x22848) or (invdrugs@mdanderson.org) 5

19 Orders: Required Elements Patient name and medical record number Date and time the order is written Protocol Number Statement whether this is a new order or a change in an existing order If applicable, all elements used to calculate the dose of a chemotherapy agent should be included on the order (height, weight, and/or BSA) Location of Administration Inpatient or Outpatient Orders Orders: Required Elements Indication that written informed consent was obtained Allergies Chemotherapy agent name, dose, route and date of administration for each drug Cycle number and/or week number as appropriate to the regimen Attending physician signature and a second signature (from another licensed health care provider) indicating a double check of dose calculation Prescriptions: Required Elements Patient name and medical record number If applicable, all elements used to calculate the dose of a chemotherapy agent should be included (height, weight, and/or BSA) Protocol Number Drug Name, Dose, Formulation, Instructions for Use Quantity Please do not use Month Supply No Refills are permitted on Investigational Prescriptions Other Pertinent Information If Chemotherapy is prescribed, please use the Chemotherapy Prescription Template Kit Number, if applicable 6

20 Mid Level Practioners The Following may NOT be ordered by Mid Level Practitioners: Controlled substances, Schedules 1 and 2 Chemotherapeutic agents Investigational drugs Radiation Therapy and radiopharmaceuticals Commercially available, agents used as supportive care part of the protocol (Not included as part of IND)- can be prescribed by Mid-Level Practitioners. This does not include Controlled Substances. Delegated Prescriptive Authority Policy: Medical Staff Policy VII.A Drug Returns Drug returns from patients should be returned to research nurses for accountability Patient Drug Returns may be stored for Sponsor review or destroyed by IPS Final accountability and destruction or return must be done within three months of receipt by IPS. All returns will be destroyed three months after drop off date. Patient Returns Accountability Record Template 7

21 Compassionate Investigational New Drug (CIND) Protocols Similar to regular protocols, we will handle the inventory procurement, record keeping, preparation, p and dispensing for CIND protocols CIND Protocols must be submitted and approved via PDOL Each Patient MUST be registered in CORe Special Issues Institutionally approved pumps and administration sets Institutional Policies and Procedures Destruction Policy Temperature Monitoring Resources Clinical Portal ( 8

22 Access to Prescription On Line (POL) Clinical Portal POL Provides the Physicians and their designated agents a quick, effective system for generating and tracking prescriptions Clinical Calculators Body Surface Area Body Mass Index Creatinine Clearance Micromedex Drug and Disease State Information Drug Interactions Patient Information Clinical Pharmacology Pharmacy and Formulary Record Request Form: Investigational Pharmacy Webite 9

23 Micromedex Clinical Pharmacology Pharmacy and Formulary 10

24

25 2/3/2009 Clinical Research Audit Program More Information Sylvie Marcy, BSN MHA Manager, Office of Research Education & Regulatory Management

26

27 Putting it all Together Leni A. Mathews Joyce E. Brown Office of Research Education and Regulatory Management Objectives Understand Life of a Protocol Identify Resources Exposure to key research items Learn a few tips to succeed in initiating and conducting clinical trials How do I get a Clinical Trial started? 1. Preparation 2. Resources 3. Organization 4. Coordination 5. Collaboration 6. Communication 7. Implementation 8. Evaluation 1

28 Protocol Life cycle Forecast Calendar Screening Baseline Enrollment Registration Randomization Active Monitoring Long Term Follow-up From NCI Website Protocol Preparation 1. Understand Protocol 2. Understand Disease Process 3. Understand Treatments and Drugs 4. Visualize your goal Protocol Resources Ask yourself Who do I need help from to conduct a particular study? Write down the names of departments or persons on a list. Here s an example: Radiation Oncology Lab medicine CTRC/ ATC Neuro Clinic Staff Diagnostic Imaging Neuro Research Staff Practice Outcomes Investigational Pharmacy Business Office 2

29 Organization Protocol Resources/ Organization What do I need to Organize myself for this protocol? Regulatory Binder Check List Cheat Sheet Phone List On Study Note Protocol Resources/ Organization What else do I need? Data Entry guide Toxicity Record Patient Diary Patient Education Material- example- Video Dictation Guide Order Sets New Patient Research Charts Follow up Packets 3

30 Protocol Resources/ Organization A few other needs: Ongoing Concomitant Medication List Tumor Measurement Documentation Sample Clinic Service Requisition Sample Orders Diagnostic/ Other testing forms Protocol Response Documentation Protocol Coordination Read the protocol and identify areas where you many need to coordinate protocol specific testing or treatments. Think about time restrictions. Examples You might have a study which requires patients to receive radiation treatment within one hour of taking a drug. You may need to obtain lab work within three hours of the drug. Think about how to coordinate all of these procedures. Protocol Collaboration Most protocols require effective collaboration. Example: Patients on drug x need a complete neurological evaluation. How do you get the Physician to complete a neurological exam at each visit per protocol? 4

31 Protocol Communication/ Implementation Communication is so important in running clinical trials Example: What if your patient is late for a treatment which is to be administered at 6am in the Infusion Center? The patient called you. Now who do you need to call? What if the patient has a full schedule of events which should fall in sequential order? Multiple Protocol Management How do I manage this protocol along with many others effectively? Organization Pocket Eligibility Cards Binder with all up to date protocols and informed consents. At least have one copy of the latest informed consent for each study- just incase. Multiple Protocol Management How do I manage many protocols and stay organized? Colored Research Charts Contact List for each protocol Detailed Instruction sheet for protocol enrollment and follow up. 5

32 Computer Review Be aware of your passwords and know how to use all the programs which you will need. Here are some of the many programs we use at MD Anderson: MD Anderson Intranet Site CORE PDMS Lotus Notes Tiles UT MDACC directory PDOL ORA MDACC IND Sponsored Studies NCI Sponsored Studies Clinic Station Departmental Folders, Spreadsheets, Excel, Access, File Maker Pro, etc. Sponsor Websites Assistance What can I do to make it easier and learn more? Attend Brown Bag Sessions Request Training Know your way around this huge place Check out Education Center on Inside MD Anderson websitehttp://inside.mdanderson.org/education/edcen ter/index.html Tips Computer- Be aware of where and how to find forms Remember your passwords Always have paper copies in case of computer outages 6

33 Short Cuts Save frequently used websites to your favorites Create short cuts to your desktop Save frequently used forms and templates Tips-Things on your desk/pocket Date Forecaster Desk Calendar ANC calculator BSA calculator online Pocket Calculator Staging Information Contact List Data Entry Keep up to date Tips 7

34 SAE Forms Tips Protocol Deviations/ Violations 4info OPR Who do I contact? Office of Research Education and Regulatory Management IRB Organization Eligibility Cards- Create Pocket Eligibility cards in various colors ID BOB COG123 PCR134 CNS23 8

35 Use Different Colored Folde 9

36 Conclusion Prepare prior to protocol initiation Adjust processes throughout protocol life Ask for help Know your resources Actually Putting it all Together Lisa Dassler Leni Mathews Activity Instructions Clear your desks of everything except a pen. Split into groups of 2. You will have one spiral notebook for your team to write on. There are various stations. You will have two minutes at each station. Each station is labeled with a number. Write down the number of the station and relevant information next to it. Move to the next station when time is called. 10

37 Putting it All Together Activity There are 10 Stations. Each station has an activity to complete. Please write down your answers for each station. Station 1 Station 2 Station 3 Station 4 Station 5

38 Station 6 Station 7 Station 8 Station 9 Station 10

Mastering Clinical Research April 19, :30 am

Mastering Clinical Research April 19, :30 am Mastering Clinical Research April 19, 2017 7:30 am New Question and Answer Response System Log In Directions Use the following link to access pre and post test questions: http://www.socrative.com/ Click

More information

QUALITY ASSURANCE PROGRAM

QUALITY ASSURANCE PROGRAM QUALITY ASSURANCE PROGRAM Elaine Armstrong, MS Quality Assurance Manager PURPOSE Verify accuracy of submitted data Verify compliance with protocol and regulatory requirements Provide educational support

More information

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 DISCLOSURE STATEMENT I have nothing to disclose regarding

More information

Effective Date: 11/09 Policy Chronicle:

Effective Date: 11/09 Policy Chronicle: Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:

More information

EMA Inspection Site perspective

EMA Inspection Site perspective EMA Inspection Site perspective Hermien Gous Wits RHI Shandukani Research Centre 27.09.2016 Cape Town Why were we inspected times? Pharmaceutical company applied for registration of the study drug in a

More information

Good Clinical Practice: A Ground Level View

Good Clinical Practice: A Ground Level View Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,

More information

Policies and Procedures for LTC

Policies and Procedures for LTC Policies and Procedures for LTC Strictly confidential This document is strictly confidential and intended for your facility only. Page ii Table of Contents 1. Introduction... 1 1.1 Purpose of this Document...

More information

Yes. Phone encounter? Part of screening process. Consent and enroll patient. Apply Treatment Plan. Verify link to Timeline. Conduct patient assessment

Yes. Phone encounter? Part of screening process. Consent and enroll patient. Apply Treatment Plan. Verify link to Timeline. Conduct patient assessment Referral - introduction to study Review consent and study Answer questions Review medical history Phone encounter? IRB approval Request required permission to schedule test (could change at screening)

More information

PHARMACY IN-SERVICE Pharmacy Procedures for New Nursing Staff

PHARMACY IN-SERVICE Pharmacy Procedures for New Nursing Staff PHARMACY IN-SERVICE Pharmacy Procedures for New Nursing Staff OVERVIEW COMMUNICATION: THE KEY TO SUCCESS GOOD COMMUNICATION BETWEEN THE FACILITY AND THE PHARMACY IS ESSENTIAL FOR EFFICIENT SERVICE AND

More information

COA ADVANCED PRACTICE PROVIDER CALL

COA ADVANCED PRACTICE PROVIDER CALL COA ADVANCED PRACTICE PROVIDER CALL Tuesday, November 15 th, 12:30 pm ET 2015 Community Oncology Alliance 1 CAPP Co-Chairs: Sarah Alexander, NP-C, Lake Norman Oncology sarah@lakenormanoncology.com Diana

More information

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual Department Policy Code: D: MM-5615 Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Chemotherapy Purpose: Ensure

More information

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies Building Quality into Clinical Trials Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies Objectives Identify strategies for developing a Quality Management

More information

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies DIRECTIONS: 1. The purpose of a regulatory binder is to assure that all essential elements are maintained in an organized

More information

a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.

a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration. Board of Pharmacy Administrative Rules Version 12 January 18, 2013 Part 19 Remote Pharmacies 19.1 General Purpose: (a) This Part is enacted pursuant to 26 V.S.A. 2032 which initially authorized the Board

More information

ASCO s Quality Training Program

ASCO s Quality Training Program ASCO s Quality Training Program Project Title: Improving the Consenting and Education Process for Patients Starting on Oral Oncology Medications Presenter s Name: Lauren Zatarain, MD Institution: Mary

More information

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY PS1006 SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY TITLE: Satellite Site Management Plan Job Title of Reviewer: POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY TYPE: Elizabeth Carr, R.N.,

More information

5. returning the medication container to proper secured storage; and

5. returning the medication container to proper secured storage; and 111-8-63-.20 Medications. (1) Self-Administration of Medications. Residents who have the cognitive and functional capacities to engage in the self-administration of medications safely and independently

More information

BIMO SITE AUDIT CHECKLIST

BIMO SITE AUDIT CHECKLIST Item AUTHORITY AND ADMINISTRATION FOR STUDIES INVOLVING HUMAN DRUGS, BIOLOGICS AND DEVICES 1. Compare the Investigator Agreement with the information provided by the assigning Center. Auditor will check

More information

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Study Management SM 306.00 STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick M. Schnell, MD,

More information

Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation

Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation Investigational Drug Service (IDS) Rotation Tool APPE Student Rotation Rotation Description The goal of an IDS rotation is introduce students to the role the Investigation Drug Service (IDS) pharmacist

More information

LOUISIANA. Downloaded January 2011

LOUISIANA. Downloaded January 2011 LOUISIANA Downloaded January 2011 SUBCHAPTER A. PHYSICIAN SERVICES 9807. Standing Orders A. Physician's standing orders are permissible but shall be individualized, taking into consideration such things

More information

Oncology Quick Start Guide

Oncology Quick Start Guide Oncology Quick Start Guide Oncology Provider - Beacon Version Date: 5/31/2017 Table of Contents Oncology Reports... 1 Treatment Plan Springboard... 1 Summary Phys Onc... 1 Summary Nurse Onc... 2 Scheduler

More information

Licensed Pharmacy Technicians Scope of Practice

Licensed Pharmacy Technicians Scope of Practice Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated

More information

Patient Safety. Road Map to Controlled Substance Diversion Prevention

Patient Safety. Road Map to Controlled Substance Diversion Prevention Patient Safety Road Map to Controlled Substance Diversion Prevention Road Map to Diversion Prevention safe S Safety Teams/ Organizational Structure A Access to information/ Accurate Reporting/ Monitoring/

More information

Research Pharmacy Services

Research Pharmacy Services Research Pharmacy Services Introduction and Overview Erin Corella, PharmD, BCPS, BCPS, Pharmacist May 25, 2016 Research Pharmacy Staff Pharmacists Jeanne Liming, PharmD, BCOP Amee Kelley, PharmD Sara Blefgen,

More information

InstyMeds Prescription Writer Tutorial

InstyMeds Prescription Writer Tutorial InstyMeds Prescription Writer Tutorial July 2014 Log in to the InstyMeds Prescription Writer tool Important messages announcing the latest enhancements and notifications are located here. 1. Type in Username

More information

managing or activities.

managing or activities. STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This

More information

Systemic anti-cancer therapy Care Pathway

Systemic anti-cancer therapy Care Pathway Network Guidance Document Status: Expiry Date: Version Number: Publication Date: Final July 2013 V2 July 2011 Page 1 of 9 Contents Contents... 2 STANDARDS FOR PREPARATION AND PHARMACY... 3 1.1 Facilities

More information

Section 9. Study Product Considerations for Non- Pharmacy Staff

Section 9. Study Product Considerations for Non- Pharmacy Staff Section 9. Study Product Considerations for Non- Pharmacy Staff Table of Contents 9.1 Dispensing Study Product 9.1.1 Chain of Custody 9.1.2 Initial Vaginal Ring Dispensing(s)- Prescription Overview 9.2

More information

ACRIN ADVERSE EVENT REPORTING MANUAL. 1 March 2006 v.3

ACRIN ADVERSE EVENT REPORTING MANUAL. 1 March 2006 v.3 AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK ADVERSE EVENT REPORTING MANUAL 1 Prepared by the American College of Radiology Imaging Network Administrative Center September 2002 Revised March 2006 American

More information

MINNESOTA. Downloaded January 2011

MINNESOTA. Downloaded January 2011 MINNESOTA Downloaded January 2011 4658.1300 MEDICATIONS AND PHARMACY SERVICES; DEFINITIONS. Subpart 1. Controlled substances. "Controlled substances" has the meaning given in Minnesota Statutes, section

More information

CHEYENNE REGIONAL MEDICAL CENTER AREA: TITLE: TrueConnect Downtime/Recovery Procedure. Page 1 of 1 NUMBER: ADMIN-IM-32 ORIGINATOR: CMIO

CHEYENNE REGIONAL MEDICAL CENTER AREA: TITLE: TrueConnect Downtime/Recovery Procedure. Page 1 of 1 NUMBER: ADMIN-IM-32 ORIGINATOR: CMIO ORIGINATOR: CMIO Page 1 of 1 POLICY APPLIES TO: Cheyenne Regional APPROVED BY: CEO: COO: CHRO: CNO: CMIO: REVISION DATE: N/A new policy EFFECTIVE DATE: March 2013 POLICY REVIEW COMMITTEE (PRC) REVIEW DATE:

More information

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8 SOP Title: Laboratory (GCLP) supervision visits Project/study: NIDIAG: this SOP applies to all NIDIAG clinical studies (WP2). 1. Scope and application

More information

Hospital Pharmacy. Tutorial Series. Title slide without an image. Tutorial series learning objectives. Tutorial overview Learning outcomes

Hospital Pharmacy. Tutorial Series. Title slide without an image. Tutorial series learning objectives. Tutorial overview Learning outcomes Hospital Pharmacy Title slide without an image Tutorial Series Tutorial series learning objectives To understand the roles of hospital pharmacists, including in the continuum of patient care. To recognise

More information

Standard Operating Procedure. References Physician Guideline: Chronic Pain, Management of

Standard Operating Procedure. References Physician Guideline: Chronic Pain, Management of Subject Chronic Pain Management Index Number GL-6171 Section Patient Care Subsection Procedures/Treatments Category Corporate Contact Holly Boisen, Ext. 55970 References Physician Guideline: Chronic Pain,

More information

Research Pharmacy Services

Research Pharmacy Services Introduction and Overview Jennifer Petrolati, PharmD, BCPS Pharmacist January 15, 2014 Research Pharmacy Staff Jennifer Petrolati, PharmD, BCPS Pharmacist Jeanne Liming, PharmD, BCOP Stephanie Kory, PharmD,

More information

Martin Health System Stuart, Florida Laboratory Services. Laboratory Services and Policies

Martin Health System Stuart, Florida Laboratory Services. Laboratory Services and Policies Martin Health System Stuart, Florida Laboratory Services Laboratory Services and Policies Service Commitment: It is the goal of the Martin Health System s Clinical Laboratory to provide the medical community

More information

(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who-

(b) Service consultation. The facility must employ or obtain the services of a licensed pharmacist who- 420-5-10-.16 Pharmacy Services. (1) The facility must provide routine and emergency drugs and biologicals to its residents, or obtain them under an agreement described in 483.75(h) of Title 42 Code of

More information

CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES

CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION MEDICATION POLICIES AND PROCEDURES TITLE 77: PUBLIC HEALTH CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER c: LONG-TERM CARE FACILITIES PART 300 SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE SECTION 300.1610 MEDICATION POLICIES

More information

VCU Clinical Research Quality Assurance Assessment

VCU Clinical Research Quality Assurance Assessment VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment

More information

NUCLEAR MEDICINE RESIDENT DUTIES

NUCLEAR MEDICINE RESIDENT DUTIES NUCLEAR MEDICINE RESIDENT DUTIES General The American Board of Radiology requires four months training in Nuclear Medicine. Residents will be assigned at least 4 rotations on service. Rotations will be

More information

Response to a Medication Error Tragedy and the Development of a Patient Safety Program. Dana-Farber Cancer Institute

Response to a Medication Error Tragedy and the Development of a Patient Safety Program. Dana-Farber Cancer Institute Response to a Medication Error Tragedy and the Development of a Patient Safety Program Dana-Farber Cancer Institute Institute of Medicine December 2010 Lawrence N Shulman, MD Chief Medical Officer and

More information

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

EMA & FDA Inspections: Site perspective. Shandukani Research Centre EMA & FDA Inspections: Site perspective Shandukani Research Centre Why were we inspected? Pharmaceutical company applied for registration of the study drug (Phase I/II dosing studies in paediatrics) Large

More information

REGISTERING A PATIENT

REGISTERING A PATIENT REGISTERING A PATIENT Patient Eligibility It is important for the institution staff to review all eligibility criteria and follow-up requirements. A patient failing to meet all protocol eligibility requirements

More information

McConnell AFB Pharmacy Frequently Asked Questions

McConnell AFB Pharmacy Frequently Asked Questions McConnell AFB Pharmacy Frequently Asked Questions (click the link in blue to be directed to the answer) 1. What are the pharmacy hours? 2. What are your busiest hours in the pharmacy? 3. When can I process

More information

Telepharmacy: How One Wyoming Pharmacy Makes it Work

Telepharmacy: How One Wyoming Pharmacy Makes it Work Telepharmacy: How One Wyoming Pharmacy Makes it Work Panel: Scot Schmidt, PharmD with Kevin Smith, Telehealth Cord. Wyoming Telehealth Network November 29, 2017 Telepharmacy: How One Wyoming Pharmacy Makes

More information

NEW JERSEY. Downloaded January 2011

NEW JERSEY. Downloaded January 2011 NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if

More information

Introduction to the Parking Lot

Introduction to the Parking Lot Introduction to the Parking Lot In ARK Epic training sessions, The Parking Lot" is used to capture all questions for which your trainer may not have an immediate answer during session. Your ARK Epic Training

More information

Go! Guide: Medication Administration

Go! Guide: Medication Administration Go! Guide: Medication Administration Introduction Medication administration is one of the most important aspects of safe patient care. The EHR assists health care professionals with safety by providing

More information

PGY-1 Pharmacy Practice

PGY-1 Pharmacy Practice Lutheran Health Network PGY-1 Pharmacy Practice Residency Program LHN Pharmacy Residency Program Mission Statement The mission of the LHN Pharmacy Residency Program is to empower pharmacy residents to

More information

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,

More information

Texas Administrative Code

Texas Administrative Code RULE 19.1501 Pharmacy Services A licensed-only facility must assist the resident in obtaining routine drugs and biologicals and make emergency drugs readily available, or obtain them under an agreement

More information

Introduction to Pharmacy Practice

Introduction to Pharmacy Practice Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians

More information

Drug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06

Drug Distribution Services for Long Term Care Facilities. Susan L. Lakey, PharmD 1/11/06 Drug Distribution Services for Long Term Care Facilities Susan L. Lakey, PharmD 1/11/06 Drug distribution The process: Receipt / transcription of order Interpretation / evaluation of order Filling and

More information

RADIATION ONCOLOGY RESIDENCY SUPERVISION POLICY

RADIATION ONCOLOGY RESIDENCY SUPERVISION POLICY RADIATION ONCOLOGY RESIDENCY SUPERVISION POLICY This policy is intended to guide the activities of radiation oncology residents in insuring that patient care activities in which residents participate are

More information

University of Miami Clinical Enterprise Technologies

University of Miami Clinical Enterprise Technologies Provider Manual 1 Our Mission: To design and deliver ongoing support for a network of Business and Clinical Information Management Systems which enhance the academic and research vision while implementing

More information

Self-Monitoring Tool

Self-Monitoring Tool This form is designed for research personnel to use to assess their compliance with TTUHSC El Paso IRB policies and procedures, and federal regulations and guidance governing research with human subjects,

More information

HELLO HEALTH TRAINING MANUAL

HELLO HEALTH TRAINING MANUAL HELLO HEALTH TRAINING MANUAL Please note: As with all training materials, the names and data used in this training manual are purely fictitious and for information and training purposes only Login/What

More information

4.7 Quality Study. Study Title: Intervention to Improve Safe, Effective And Timely Oral Chemotherapy Administration and Documentation

4.7 Quality Study. Study Title: Intervention to Improve Safe, Effective And Timely Oral Chemotherapy Administration and Documentation 4.7 Quality Study Study Title: Intervention to Improve Safe, Effective And Timely Oral Chemotherapy Administration and Documentation 2015 1 Problem Statement There are an increasing number of anticancer

More information

Checklist prior to recruiting first patient

Checklist prior to recruiting first patient Pre-Site selection Site Initiation Visit (SIV) What kind of questions should you ask How you should prepare for this visit Delegation logs Training logs ECRF/CRF Checklist prior to recruiting first patient

More information

Pharmaceutical Services Requirements: formerly 10D and 10C.7

Pharmaceutical Services Requirements: formerly 10D and 10C.7 Pharmaceutical Services Requirements: formerly 10D.28-29 and 10C.7 Frank S. Emanuel, Pharm.D., FASHP Associate Professor/Division Director Florida A and M University College of Pharmacy Jacksonville Disclosure

More information

PHARMACEUTICALS AND MEDICATIONS

PHARMACEUTICALS AND MEDICATIONS DESCHUTES COUNTY ADULT JAIL CD-10-17 L. Shane Nelson, Sheriff Jail Operations Approved by: December 6, 2017 POLICY. PHARMACEUTICALS AND MEDICATIONS It is the policy of Deschutes County Sheriff s Office

More information

Study Monitoring Plan Template

Study Monitoring Plan Template Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &

More information

SECTION HOSPITALS: OTHER HEALTH FACILITIES

SECTION HOSPITALS: OTHER HEALTH FACILITIES SECTION.1400 - HOSPITALS: OTHER HEALTH FACILITIES 21 NCAC 46.1401 REGISTRATION AND PERMITS (a) Registration Required. All places providing services which embrace the practice of pharmacy shall register

More information

VISIT NOTES QUIZ. C. Individually select each system, then select the negative box for each item

VISIT NOTES QUIZ. C. Individually select each system, then select the negative box for each item VISIT NOTES QUIZ 1. In the Examination section of the visit note template, how would you quickly mark all sections of the exam as normal? A. Select (-) at the top of the template B. Select the negative

More information

The GCP Perspective on Study Monitoring

The GCP Perspective on Study Monitoring The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,

More information

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements 6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services

More information

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months.

C. Physician s orders for medication, treatment, care and diet shall be reviewed and reordered no less frequently than every two (2) months. SECTION 1300 - MEDICATION MANAGEMENT 1301. General A. Medications, including controlled substances, medical supplies, and those items necessary for the rendering of first aid shall be properly managed

More information

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18 SOP #: RCO-204 Page: 1 of 5 1. POLICY STATEMENT: The research team is responsible for recognizing changes in subject health that may qualify as adverse events, classifying those results as defined in the

More information

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

CONSULTANT PHARMACIST INSPECTION LAW REVIEW CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE MANAGEMENT OF PATIENT S OWN MEDICATIONS SCOPE Provincial: Inpatient Settings, Ambulatory Services, and Residential Addiction and Detoxification Settings APPROVAL AUTHORITY Clinical Operations Executive

More information

Audience Poll Questions

Audience Poll Questions Pharmacy Drug Procedures and Proper Documentation Ana Fernandez, CPhT Northwestern Memorial Hospital Department of Investigational Drug Chicago, Illinois The speaker has no conflicts to disclose. Audience

More information

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved

More information

Please adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home?

Please adjust your computer volume to a comfortable listening level. This is lesson 4 How do you handle medication at home? Welcome to the Pennsylvania Department of Public Welfare (DPW), Office of Developmental Programs (ODP) Medication Administration Course for life sharers. This course was developed by the ODP Office of

More information

Managing Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers

Managing Treatment With Oral Oncology Medications. An Educational Toolkit for Health Care Providers Managing Treatment With Oral Oncology Medications An Educational Toolkit for Health Care Providers Acknowledgment Novartis Pharmaceuticals Corporation would like to thank Jody Pelusi, PhD, FNP, AOCNP,

More information

CPhT Program Recognition Attestation Form

CPhT Program Recognition Attestation Form About this Form Beginning in 2020, CPhT applicants must have completed a PTCB-recognized education/training program or have equivalent work experience in order to be eligible for certification. The purpose

More information

The presenter has owns Kelly Willenberg, LLC in relation to this educational activity.

The presenter has owns Kelly Willenberg, LLC in relation to this educational activity. Kelly M Willenberg, MBA, BSN, CCRP, CHC, CHRC 1 The presenter has owns Kelly Willenberg, LLC in relation to this educational activity. 2 1 Medical Necessity when you submit claims Coding for qualifying

More information

Stephen T. Pittenger, DVM, DABVP 9/20/2013

Stephen T. Pittenger, DVM, DABVP 9/20/2013 Dr. Stephen Pittenger Memorial 610 Hospital for Animals Houston, Texas How does this differ from the Outpatient setting? Longer admission Less inherent structure to visits More staff interact with the

More information

Optimizing Medication Safety in Maryland Assisted Living Facilities. Panel Discussion Moderated by: Nicole Brandt, PharmD

Optimizing Medication Safety in Maryland Assisted Living Facilities. Panel Discussion Moderated by: Nicole Brandt, PharmD Optimizing Medication Safety in Maryland Assisted Living Facilities Panel Discussion Moderated by: Nicole Brandt, PharmD 11 Objectives At the end of this knowledge based activity, the participants should

More information

Medication Reconciliation

Medication Reconciliation Medication Reconciliation Where are we now? Angie Powell, PharmD Director of Pharmacy Baxter Regional Medical Center Disclosures I, Angie Powell, have no relevant financial relationships to disclose. Learning

More information

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information PP-501.00 SOP For Safeguarding Protected Health Information Effective date of version: 01 April 2012 Study Management PP 501.00 STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

More information

GCP INSPECTION CHECKLIST

GCP INSPECTION CHECKLIST (This list is not all inclusive; item may be added &/or deleted as per the Study/Site/Sponsor/Lab) I. General. Name and address of the clinical trial site Tel. No. & e- mail:. Date of Inspection. Inspection

More information

Administration of Chemotherapeutic Agents

Administration of Chemotherapeutic Agents Administration of Chemotherapeutic Agents Contributed by The Outer Banks Hospital Nags Head, NC Leading Practices Library Organizations submit practices to The Joint Commission that they have found to

More information

Setting up a Clinical Trial

Setting up a Clinical Trial York Foundation Trust R&D Unit SOP Pharm/S45 Setting up a Clinical Trial IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING USED All staff should regularly check

More information

EMR Downtime Business Continuity Plan

EMR Downtime Business Continuity Plan Contents A - Business Continuity Plan... 2 Planned Downtime... 2 Unplanned Downtime... 2 724 Access Viewer... 2 Initiating Code Yellow... 3 Initiating a Downtime... 3 PAS (HOMER) is down... 8 Network Down

More information

Clinical Trial Readiness Checklist October 2014

Clinical Trial Readiness Checklist October 2014 The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the

More information

Bar Code Medication Administration and MAR Resource Manual

Bar Code Medication Administration and MAR Resource Manual Bar Code Medication Administration and MAR Resource Manual Administering Medications Administering Meds using CareMobile (PDA)... 2 Viewing Allergies in CareMobile... 8 Determining Which Meds to Give When...

More information

Care Management Policies

Care Management Policies POLICY: Category: Care Management Policies Care Management 2.1 Patient Tracking and Registry Functions Effective Date: Est. 12/1/2010 Revised Date: Purpose: To ensure management and monitoring of patient

More information

Medication Management Policy and Procedures

Medication Management Policy and Procedures POLICY STATEMENT This policy establishes guidelines for ensuring safe and correct management of client medications in accordance with legislative and regulatory requirements and professional practice competency

More information

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees Location: Los Angeles Research Institute: Los Angeles, CA Investigation Product/Test Article: Laftr Visit Mechanism: On-site Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009

More information

H2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome

H2H Mind Your Meds Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome H2H Mind Your Meds "Challenge Webinar #3- Lessons Learned Wednesday, April 18, 2012 2:00 pm 3:00 pm ET 1 Welcome Take Home Messages Understand how to implement the Mind Your Meds strategies and tools in

More information

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both

More information

CRAIG HOSPITAL POLICY/PROCEDURE

CRAIG HOSPITAL POLICY/PROCEDURE CRAIG HOSPITAL POLICY/PROCEDURE Approved: P&T, MEC, NPC, P&P 03/09 Effective Date: 02/95 P&T, MEC, P&P 08/09; P&P 08/10; P&T, MEC 10/10, P&T, P&P 12/10 ; MEC 01/11; P&T, MEC 02/11, 04/11 ; P&T, P&P 12/11

More information

ASCO s Quality Training Program

ASCO s Quality Training Program ASCO s Quality Training Program Project Title: Reduction of Time from Admission to Initiation of Chemotherapy on Inpatient Hematology and Bone Marrow Transplant Services Presenter s Name: Ryan J. Mattison,

More information

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 TITLE / DESCRIPTION: SAFETY PROCEDURES FOR MEDICATION USE DEPARTMENT: Pharmacy PERSONNEL: All Pharmacy Personnel EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014 Leadership and Culture A culture

More information

Effectively Managing and Monitoring Controlled Substances in Research

Effectively Managing and Monitoring Controlled Substances in Research Effectively Managing and Monitoring Controlled Substances in Research Emmelyn Kim, MA, MPH, CCRA, CHRC AVP, Research Compliance & Privacy Officer Ji Eun Kim, PhD, RPh Research Pharmacist The Office of

More information

Topics 5/16/2017. Effectively Managing and Monitoring Controlled Substances in Research

Topics 5/16/2017. Effectively Managing and Monitoring Controlled Substances in Research Effectively Managing and Monitoring Controlled Substances in Research Emmelyn Kim, MA, MPH, CCRA, CHRC AVP, Research Compliance & Privacy Officer Ji Eun Kim, PhD, RPh Research Pharmacist The Office of

More information

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017 PLATELET-ORIENTED INHIBITION IN NEW TIA AND MINOR ISCHEMIC STROKE (POINT) MONITORING PLAN Version 2.0 Updated 11 May 2017 Monitoring Plan Table of Contents 1.0 Introduction... 4 2.0 Purpose... 4 3.0 Review

More information

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records; TEXAS HEALTH RESOUCES Table 17-III. Record Retention Schedule Human Subject Research Records and Documents Approved by THR System Performance Council (SPC): 19 January 2010 Effective Date: October 14,

More information

QUALITY MANAGEMENT PROGRAM FOR HUMAN RESEARCH SUBJECT UNIVERSITY OF CINCINNATI

QUALITY MANAGEMENT PROGRAM FOR HUMAN RESEARCH SUBJECT UNIVERSITY OF CINCINNATI Effective January 27, 1992 Modified: August 10, 1993; March 8, 1994; August 11, 1994; July 18, 1995; September 23, 1997, November 14, 2001, May 19, 2004, June 17, 2006 and (November 8, 2006) I. Purpose

More information